INDIAN JOURNAL OF PHARMACOLOGY

Scope & Guideline

Advancing pharmacological knowledge for a healthier tomorrow.

Introduction

Delve into the academic richness of INDIAN JOURNAL OF PHARMACOLOGY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0253-7613
PublisherWOLTERS KLUWER MEDKNOW PUBLICATIONS
Support Open AccessNo
CountryIndia
TypeJournal
Convergefrom 1978 to 1980, 1982, from 1984 to 1986, from 1994 to 2024
AbbreviationINDIAN J PHARMACOL / Indian J. Pharmacol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressWOLTERS KLUWER INDIA PVT LTD, A-202, 2ND FLR, QUBE, C T S NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra 400059, INDIA

Aims and Scopes

The Indian Journal of Pharmacology focuses on various aspects of pharmacology, including drug development, clinical pharmacology, pharmacovigilance, and the therapeutic efficacy of medicinal compounds. It aims to bridge the gap between laboratory research and clinical practice, providing a platform for innovative studies and reviews that advance the field of pharmacology.
  1. Clinical Pharmacology and Therapeutics:
    Research on the effects of drugs in humans, focusing on their efficacy, safety, and optimal use in clinical settings. This includes studies on drug interactions, adverse effects, and therapeutic outcomes.
  2. Pharmacovigilance and Drug Safety:
    Studies that monitor and evaluate the safety of medications post-marketing, including adverse drug reactions and their management. The journal emphasizes the importance of reporting and analyzing drug-related adverse events.
  3. Natural Products and Traditional Medicine:
    Research investigating the pharmacological properties of natural compounds, including herbal medicines and their efficacy in treating various diseases. This area highlights the relevance of traditional medicine in modern pharmacological practices.
  4. Innovations in Drug Development:
    Papers focusing on new drug formulations, delivery systems, and therapeutic strategies, including the use of nanotechnology and computational methods in drug discovery.
  5. Experimental and Preclinical Studies:
    Research utilizing animal models to understand drug mechanisms, efficacy, and safety before clinical trials. This includes studies on pharmacokinetics and pharmacodynamics.
  6. Public Health and Epidemiology:
    Research addressing the impact of pharmacological interventions on public health, including studies on drug accessibility, prescribing patterns, and the role of pharmacology in managing infectious diseases.
Recent publications in the Indian Journal of Pharmacology indicate several emerging themes that reflect current challenges and advancements in the field. These trends highlight the journal's responsiveness to contemporary issues in pharmacology and medicine.
  1. Impact of COVID-19 on Pharmacology:
    A significant number of recent articles address the pharmacological implications of COVID-19, including drug repurposing, vaccine development, and management of post-COVID complications, underscoring the pandemic's influence on research priorities.
  2. Artificial Intelligence and Machine Learning in Drug Development:
    There is a growing interest in the application of AI and machine learning in pharmacological research, particularly in experimental design and data analysis, showcasing a trend towards integrating technology in drug discovery.
  3. Neuropharmacology and Mental Health:
    An increasing number of studies focus on neuropharmacological agents and their effects on mental health disorders, reflecting a broader understanding of the importance of mental health in pharmacological research.
  4. Natural Products and Phytotherapy:
    Research on natural products is gaining momentum, with a focus on their pharmacological potential and mechanisms of action, indicating a resurgence in interest in herbal medicine and its therapeutic applications.
  5. Pharmacovigilance and Safety Monitoring:
    There is an upward trend in research dedicated to pharmacovigilance, emphasizing the need for ongoing safety monitoring of medications and the importance of understanding adverse drug reactions in clinical practice.

Declining or Waning

While the Indian Journal of Pharmacology has consistently published papers across a wide range of topics, certain themes have shown a decline in prominence over recent years. This may reflect shifts in research priorities or emerging interests within the field.
  1. Traditional and Alternative Medicine:
    Although still relevant, there has been a noticeable decline in the number of papers focusing solely on traditional and alternative medicinal practices. This could indicate a shift towards more evidence-based approaches in pharmacology.
  2. Basic Pharmacological Mechanisms:
    Research solely dedicated to fundamental pharmacological mechanisms appears to be waning, as the focus moves towards clinical applications and translational research.
  3. Pharmacogenetics and Personalized Medicine:
    While once a hot topic, there seems to be a decrease in publications centered on pharmacogenetics, possibly due to a greater emphasis on broader clinical applications rather than genetic factors influencing drug responses.
  4. Drug Regulation and Policy:
    There has been less emphasis on studies related to drug regulation and policy in recent publications, suggesting a potential gap in exploring the implications of pharmacological practices on healthcare systems.

Similar Journals

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS

Pioneering Pharmacological Solutions for Veterinary Challenges
Publisher: WILEYISSN: 0140-7783Frequency: 6 issues/year

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS is a crucial publication in the field of veterinary medicine, dedicated to advancing knowledge and practices related to pharmacology and therapeutic interventions in animals. Published by WILEY, this peer-reviewed journal has been a reliable source of innovative research since its inception in 1978, and it continues to play an integral role in shaping veterinary pharmacology through its commitment to high-quality scientific discourse. With an impact factor reflective of its robust academic standing, the journal is categorized in the Q3 quartile for Pharmacology and Q2 for Veterinary (miscellaneous) as of 2023, highlighting its relevance and significance within these domains. It is indexed in Scopus with commendable rankings, particularly in General Veterinary, where it ranks #45 out of 194, placing it in the 77th percentile. This journal not only offers a platform for original research articles but also caters to the dissemination of practical applications and reviews that are essential for veterinarians, researchers, and students alike in enhancing animal health and welfare. Although not an open-access publication, its contributions remain accessible to those engaged in the veterinary sciences through institutional subscriptions. The journal's enduring legacy and forward-looking approach make it a vital resource for anyone interested in veterinary therapeutics and pharmacology.

Ars Pharmaceutica

Fostering collaboration for transformative pharmaceutical insights.
Publisher: UNIV GRANADA, EDITORIALISSN: 0004-2927Frequency: 4 issues/year

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

International Journal of Pharmacology

Fostering Global Dialogue in Pharmacology and Toxicology
Publisher: ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINETISSN: 1811-7775Frequency: 8 issues/year

Welcome to the International Journal of Pharmacology, a key publication in the field of pharmacology, published by ASIAN NETWORK SCIENTIFIC INFORMATION (ANSINET). Since its inception in 2006, this journal has provided a vital platform for researchers and professionals to disseminate their findings and insights in pharmacology, toxicology, and pharmaceutics. Despite recent discontinuation in Scopus coverage, the journal's dedication to fostering scientific dialogue continues to attract contributions from esteemed scholars globally. With an **ISSN of 1811-7775** and **E-ISSN of 1812-5700**, the journal seeks to bridge the gap between laboratory research and clinical application, promoting a deeper understanding of drug actions and interactions. Although it operates under traditional access options, the relevance of its published studies to ongoing pharmacological research remains significant.

BMC Pharmacology & Toxicology

Exploring the dynamic interplay of drugs and biology.
Publisher: BMCISSN: Frequency: 1 issue/year

Welcome to BMC Pharmacology & Toxicology, a premier open-access journal dedicated to advancing the fields of pharmacology and toxicology. Published by BMC since 2012, this esteemed journal offers a platform for researchers, professionals, and students to disseminate cutting-edge research and innovative findings that explore the intricate interactions between drugs and biological systems. With its robust Q2 ranking in both general medicine and pharmacology categories for 2023, BMC Pharmacology & Toxicology is recognized for its significant contributions to the academic community, reflected in its strategic positioning within the 61st and 49th percentiles in Scopus rankings for related disciplines. The journal's commitment to open access ensures that vital research is accessible to a global audience, fostering collaboration and informed discussions. We invite you to engage with the latest studies, reviews, and innovative methodologies that shape the future of pharmacological and toxicological sciences.

SCIENTIA PHARMACEUTICA

Advancing pharmaceutical science for a healthier tomorrow.
Publisher: MDPIISSN: Frequency: 4 issues/year

SCIENTIA PHARMACEUTICA, published by MDPI in Switzerland, is a leading open access journal dedicated to advancing the field of pharmaceutical sciences since 2006. With a focus on pharmacology, toxicology, and pharmaceutics, this journal plays a pivotal role in disseminating high-quality research and innovative findings. It boasts an impressive impact factor and is ranked in the second quartile (Q2) for Pharmaceutical Science, signifying its influence within the academic community, aided by a Scopus ranking of 74 out of 183 journals in the same category. SCIENTIA PHARMACEUTICA invites original research articles, reviews, and notes that contribute to the understanding and development of pharmaceutical science, making it an essential resource for researchers, professionals, and students alike seeking to stay at the forefront of this continuously evolving field. For those interested in broadening their knowledge and sharing insights, the journal ensures wide accessibility, supporting the open access model for maximum outreach.

DARU-Journal of Pharmaceutical Sciences

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: SPRINGER INT PUBL AGISSN: Frequency: 2 issues/year

DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.

JOURNAL OF CLINICAL PHARMACOLOGY

Innovating Insights in Clinical Pharmacology
Publisher: WILEYISSN: 0091-2700Frequency: 12 issues/year

Welcome to the Journal of Clinical Pharmacology, an esteemed publication in the field of pharmacology and medical pharmacology, published by Wiley. Since its inception in 1973, this journal has been at the forefront of disseminating innovative research findings and comprehensive reviews that enhance our understanding of drug therapies and their clinical applications. With an impact factor that reflects its strong reputation and a Scopus ranking placing it in the 64th percentile among 272 journals in medical pharmacology, the journal stands as a critical resource for researchers, healthcare professionals, and students alike. Although currently not an Open Access journal, it provides invaluable insights into therapeutic drug use and safety, the pharmacokinetics of drugs, and the development of new therapeutic strategies. The journal's commitment to advancing the field through high-quality, peer-reviewed articles ensures it remains a vital asset in the continuously evolving landscape of clinical pharmacology.

BIOLOGICAL & PHARMACEUTICAL BULLETIN

Elevating Knowledge in Medicine and Drug Innovation
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0918-6158Frequency: 12 issues/year

BIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Leading the Charge in Medical Pharmacology Advancements
Publisher: WILEYISSN: 0306-5251Frequency: 12 issues/year

British Journal of Clinical Pharmacology, published by Wiley, is a premier peer-reviewed journal that has been at the forefront of pharmacology research since its inception in 1974. Renowned for its high academic rigor, it stands out with an impressive impact factor that places it in the Q1 quartile within both the general pharmacology and medical pharmacology categories. With a Scopus ranking reflecting its esteemed status—ranked #68 out of 272 in medical pharmacology and #109 out of 313 in pharmacology, toxicology, and pharmaceutics—the journal serves as a critical resource for researchers, clinicians, and students who are keen to explore innovations and advancements in drug therapy. The journal's scope encompasses a wide array of topics, including clinical trials, drug safety, and pharmacokinetics, making it an essential platform for disseminating cutting-edge pharmacological findings. Although it does not offer open access, the stringent selection of articles ensures that only the highest-quality research is published, further contributing to the ongoing discourse in clinical pharmacology.

Drug Research

Advancing the Frontiers of Pharmacology
Publisher: GEORG THIEME VERLAG KGISSN: 2194-9379Frequency: 9 issues/year

Drug Research, published by GEORG THIEME VERLAG KG, is a pivotal journal housed in the vibrant realm of pharmacology and drug discovery. With a commitment to advancing the understanding of medicinal substances, this journal serves as an essential resource for researchers, professionals, and students dedicated to the field. The journal boasts an ISSN of 2194-9379 and an E-ISSN of 2194-9387, reflecting its dual commitment to print and digital accessibility. Despite its status as a Q3 journal in both Drug Discovery and Miscellaneous Medicine categories as of 2023, it continues to offer valuable insights with a focus on the latest innovations, methodologies, and findings in drug research. Based in Germany, Drug Research promotes scholarly communication and collaboration within the scientific community, ensuring that its contributions remain impactful in shaping future therapeutic discoveries. The journal is indexed in relevant databases, enhancing its visibility and reach, thus fostering a robust academic dialogue.